 - Hormonal therapy e.g., androgen receptor AR antagonists, 5 alpha reductase inhibitors, estrogens Note: Treatment with bicalutamide and nilutamide within 4 weeks prior to enrollment is not allowed. Treatment with flutamide within 4 weeks prior to enrollment is not allowed. Treatment with all other gonadotropin- releasing hormone GnRH analogues or antagonists is allowed. 